24/7 Market News Snapshot 04 March, 2025 – ChromaDex Corporation (NASDAQ:CDXC)
DENVER, Colo., 04 March, 2025 (247marketnews.com) – (NASDAQ:CDXC) are discussed in this article.
ChromaDex Corporation has demonstrated robust stock performance in recent trading, opening at $5.54 and currently sitting at $5.915—a gain of 7.55% from the previous session’s close at $5.50. The significant trading activity, with a volume of 1.09 million shares, highlights increased investor interest and confidence. This upward trend may indicate a potential breakout, particularly if the stock can maintain support at $5.50 and challenge resistance near $6.00.
In conjunction with this positive market activity, ChromaDex has announced impressive financial results for the fourth quarter and full fiscal year 2024. The company reported quarterly net sales of $29.1 million, a notable 37% increase year over year, driven largely by their flagship product, Tru Niagen®, which contributed $22.7 million in sales—a 29% rise from the previous year. Furthermore, gross margins improved to 62.5%, compared to 61.0% a year ago, reflecting efficient cost management and operational productivity.
The company achieved a net income of $7.2 million for Q4, a significant increase from a mere $0.1 million in the same quarter last year, resulting in earnings per share of $0.09. For the full fiscal year, ChromaDex reported total net sales of $99.6 million, an increase of 19%, buoyed by strong e-commerce activities and sales of proprietary ingredients. The company reversed the previous year’s losses, finishing with a net income of $8.6 million and demonstrating positive cash flow from operations of $12.1 million, ultimately enhancing its cash reserves to $44.7 million with no outstanding debt.
CEO Rob Fried emphasized the company’s commitment to innovation and shareholder value, citing the successful launch of new product lines and regulatory achievements as critical components of ChromaDex’s strategy moving forward. With a strong financial foundation, the company is well-positioned to sustain its growth and expand its market presence in health and wellness.